scholarly journals Influenza virus neuraminidase regulates host CD8+ T-cell response in mice

2020 ◽  
Vol 3 (1) ◽  
Author(s):  
Chung-Yi Wu ◽  
Hong-Yang Chuang ◽  
Chi-Huey Wong

AbstractInfluenza A virus (IAV)-specific CD8+ T-cell response was shown to provide protection against pandemic and seasonal influenza infections. However, the response was often relatively weak and the mechanism was unclear. Here, we show that the composition of IAV released from infected cells is regulated by the neuraminidase (NA) activity and the cells infected by NA-defective virus cause intracellular viral protein accumulation and cell death. In addition, after uptake of NA-defective viruses by dendritic cells (DCs), an expression of the major histocompatibility complex class I is induced to activate IAV-specific CD8+ T-cell response. When mice were infected by NA-defective IAV, a CD8+ T-cell response to the highly conserved viral antigens including PB1, NP, HA, M1, M2 and NS1 was observed along with the increasing expression of IL10, IL12 and IL27. Vaccination of mice with NA-defective H1N1 A/WSN/33 induced a strong IAV-specific CD8+ T cell response against H1N1, H3N2 and H5N1. This study reveals the role of NA in the IAV-specific CD8+ T-cell response and virion assembly process, and provides an alternative direction toward the development of universal influenza vaccines.

2011 ◽  
Vol 186 (10) ◽  
pp. 5590-5602 ◽  
Author(s):  
Christophe Paget ◽  
Stoyan Ivanov ◽  
Josette Fontaine ◽  
Fany Blanc ◽  
Muriel Pichavant ◽  
...  

2012 ◽  
Vol 189 (8) ◽  
pp. 3905-3913 ◽  
Author(s):  
Susanna Choi ◽  
Hang-Rae Kim ◽  
Lin Leng ◽  
Insoo Kang ◽  
William L. Jorgensen ◽  
...  

1999 ◽  
Vol 6 (s1) ◽  
pp. 36-40 ◽  
Author(s):  
G. R. Pape ◽  
T. J. Gerlach ◽  
H. M. Diepolder ◽  
N. Grüner ◽  
M.‐C. Jung ◽  
...  

2018 ◽  
Author(s):  
Xiaoyan Zheng ◽  
Jennifer Dora Oduro ◽  
Julia Désirée Boehme ◽  
Lisa Borkner ◽  
Thomas Ebensen ◽  
...  

Cytomegalovirus (CMV) is a ubiquitous β-herpesvirus that establishes life-long latent infection in a high percentage of the population worldwide. CMV induces the strongest and most durable CD8+ T cell response known in human clinical medicine. Due to its unique properties, the virus represents a promising candidate vaccine vector for the induction of persistent cellular immunity. To take advantage of this, we constructed a recombinant murine CMV (MCMV) expressing an MHC-I restricted epitope from influenza A virus (IAV) H1N1 within the immediate early 2 (ie2) gene. Only mice that were immunized intranasally (i.n.) were capable of controlling IAV infection, despite the greater potency of the intraperitoneally (i.p.) vaccination in inducing a systemic IAV-specific CD8+ T cell response. The protective capacity of the i.n. immunization was associated with its ability to induce IAV-specific tissue-resident memory CD8+ T (CD8TRM) cells in the lungs. Our data demonstrate that the protective effect exerted by the i.n. immunization was critically mediated by antigen-specific CD8+ T cells. CD8TRM cells promoted the induction of IFNγ and chemokines that facilitate the recruitment of antigen-specific CD8+ T cells to the lungs. Overall, our results showed that locally applied MCMV vectors could induce mucosal immunity at sites of entry, providing superior immune protection against respiratory infections.


1981 ◽  
Vol 65 (1) ◽  
pp. 103-114 ◽  
Author(s):  
Mohan L. Sopori ◽  
James M. Sheil ◽  
Thomas L. Roszman ◽  
William H. Brooks

1999 ◽  
Vol 194 (2) ◽  
pp. 178-185 ◽  
Author(s):  
Goro Matsuzaki ◽  
H.Martin Vordermeier ◽  
Asako Hashimoto ◽  
Kikuo Nomoto ◽  
Juraj Ivanyi

2011 ◽  
Vol 86 (5) ◽  
pp. 2817-2825 ◽  
Author(s):  
R. J. Betts ◽  
N. Prabhu ◽  
A. W. S. Ho ◽  
F. C. Lew ◽  
P. E. Hutchinson ◽  
...  

2007 ◽  
Vol 132 (2) ◽  
pp. 654-666 ◽  
Author(s):  
David E. Kaplan ◽  
Kazushi Sugimoto ◽  
Kimberly Newton ◽  
Mary E. Valiga ◽  
Fusao Ikeda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document